Work

A single arm phase II trial of gemcitabine (G) and irinotecan (I) in metastatic breast cancer: Can localization of topoisomerase I (topo I) predict response to topo I inhibitors?

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.661

Authors: S. L. Moulder, N. Valkov, S. Minton, P. Munster, J. Gump, M. Lacevic, C. Rocha-Lima, J. Horton, R. Lush, D. Sullivan

Institutions: The University of Texas MD Anderson Cancer Center, University of Miami, Moffitt Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2965847700

Cites:

Cited by: 2

Related to: 10